The second person with Ebola Virus Disease (EVD) is scheduled to be admitted for treatment of the lethal virus tomorrow at the National Institutes of Health (NIH) in Bethesda, MD.

This digitally-colorized scanning electron micrograph (SEM) depicts a number of filamentous Ebola virus particles (red) that had budded from the surface of a VERO cell (blue-gray) of the African green monkey kidney epithelial cell line./NIAID
This digitally-colorized scanning electron micrograph (SEM) depicts a number of filamentous Ebola virus particles (red) that had budded from the surface of a VERO cell (blue-gray) of the African green monkey kidney epithelial cell line./NIAID

The unidentified American healthcare worker who has tested positive for Ebola virus disease contracted the virus while volunteering at a Ebola treatment unit in Sierra Leone.

The individual will be transported back to the United States in isolation via a chartered aircraft. The individual will be admitted and treated at the NIH Clinical Center Special Clinical Studies Unit, a high-level containment facility which is one of a small number of such facilities in the United States. No additional details about the patient are being shared at this time.

This will be the second EVD patient to be treated at the specialized facility just northwest of Washington, DC. In October 2014, Texas Health Presbyterian Hospital nurse, Nina Pham, was treated successfully and released free of disease.

The NIH Clinical Center also admitted two individuals who experienced high-risk exposures to the Ebola virus while working on the Ebola response in West Africa, but who were ultimately found not to be infected.